Agilent Technologies Operating Margin 2012-2025 | A
Current and historical operating margin for Agilent Technologies (A) over the last 10 years. The current operating profit margin for Agilent Technologies as of October 31, 2025 is 22.91%.
| Agilent Technologies Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-10-31 | $6.95B | $1.48B | 21.29% |
| 2025-07-31 | $6.79B | $1.44B | 21.27% |
| 2025-04-30 | $6.63B | $1.42B | 21.38% |
| 2025-01-31 | $6.53B | $1.48B | 22.65% |
| 2024-10-31 | $6.51B | $1.49B | 22.86% |
| 2024-07-31 | $6.50B | $1.49B | 22.90% |
| 2024-04-30 | $6.59B | $1.29B | 19.54% |
| 2024-01-31 | $6.74B | $1.31B | 19.42% |
| 2023-10-31 | $6.83B | $1.35B | 19.76% |
| 2023-07-31 | $6.99B | $1.41B | 20.20% |
| 2023-04-30 | $7.04B | $1.69B | 24.02% |
| 2023-01-31 | $6.93B | $1.67B | 24.07% |
| 2022-10-31 | $6.85B | $1.62B | 23.63% |
| 2022-07-31 | $6.66B | $1.54B | 23.16% |
| 2022-04-30 | $6.53B | $1.47B | 22.48% |
| 2022-01-31 | $6.45B | $1.40B | 21.64% |
| 2021-10-31 | $6.32B | $1.35B | 21.32% |
| 2021-07-31 | $6.14B | $1.25B | 20.37% |
| 2021-04-30 | $5.82B | $1.15B | 19.68% |
| 2021-01-31 | $5.53B | $0.96B | 17.34% |
| 2020-10-31 | $5.34B | $0.85B | 15.85% |
| 2020-07-31 | $5.22B | $0.80B | 15.26% |
| 2020-04-30 | $5.24B | $0.79B | 15.13% |
| 2020-01-31 | $5.24B | $0.91B | 17.30% |
| 2019-10-31 | $5.16B | $0.94B | 18.23% |
| 2019-07-31 | $5.09B | $0.94B | 18.37% |
| 2019-04-30 | $5.02B | $0.93B | 18.55% |
| 2019-01-31 | $4.99B | $0.93B | 18.55% |
| 2018-10-31 | $4.91B | $0.90B | 18.40% |
| 2018-07-31 | $4.81B | $0.86B | 17.86% |
| 2018-04-30 | $4.72B | $0.84B | 17.78% |
| 2018-01-31 | $4.62B | $0.83B | 17.98% |
| 2017-10-31 | $4.47B | $0.81B | 18.05% |
| 2017-07-31 | $4.39B | $0.79B | 18.00% |
| 2017-04-30 | $4.32B | $0.74B | 17.02% |
| 2017-01-31 | $4.24B | $0.67B | 15.70% |
| 2016-10-31 | $4.20B | $0.62B | 14.64% |
| 2016-07-31 | $4.13B | $0.59B | 14.25% |
| 2016-04-30 | $4.10B | $0.59B | 14.31% |
| 2016-01-31 | $4.04B | $0.56B | 13.91% |
| 2015-10-31 | $4.04B | $0.52B | 12.93% |
| 2015-07-31 | $4.81B | $0.54B | 11.23% |
| 2015-04-30 | $4.80B | $0.53B | 10.97% |
| 2015-01-31 | $4.83B | $0.51B | 10.65% |
| 2014-10-31 | $4.81B | $0.52B | 10.87% |
| 2014-07-31 | $4.72B | $0.63B | 13.42% |
| 2014-04-30 | $5.37B | $0.74B | 13.77% |
| 2014-01-31 | $6.11B | $0.86B | 14.04% |
| 2013-10-31 | $6.78B | $0.95B | 14.02% |
| 2013-07-31 | $6.83B | $0.94B | 13.82% |
| 2013-04-30 | $6.90B | $0.98B | 14.17% |
| 2013-01-31 | $6.90B | $1.07B | 15.43% |
| 2012-10-31 | $6.86B | $1.12B | 16.32% |
| 2012-07-31 | $6.82B | $1.15B | 16.92% |
| 2012-04-30 | $6.79B | $1.17B | 17.17% |
| 2012-01-31 | $6.73B | $1.13B | 16.80% |
| 2011-10-31 | $6.62B | $1.07B | 16.19% |
| 2011-07-31 | $6.46B | $0.96B | 14.87% |
| 2011-04-30 | $6.16B | $0.80B | 12.91% |
| 2011-01-31 | $5.75B | $0.68B | 11.88% |
| 2010-10-31 | $5.44B | $0.57B | 10.40% |
| 2010-07-31 | $5.04B | $0.43B | 8.62% |
| 2010-04-30 | $4.71B | $0.32B | 6.75% |
| 2010-01-31 | $4.53B | $0.12B | 2.58% |
| 2009-10-31 | $4.48B | $0.05B | 1.05% |
| 2009-07-31 | $4.80B | $0.23B | 4.75% |
| 2009-04-30 | $5.18B | $0.45B | 8.63% |
| 2009-01-31 | $5.55B | $0.69B | 12.35% |
| 2008-10-31 | $5.77B | $0.80B | 13.77% |
| 2008-07-31 | $5.74B | $0.73B | 12.77% |
| 2008-04-30 | $5.67B | $0.68B | 12.05% |
| 2008-01-31 | $5.53B | $0.62B | 11.26% |
| 2007-10-31 | $5.42B | $0.58B | 10.77% |
| 2007-07-31 | $5.30B | $0.54B | 10.24% |
| 2007-04-30 | $5.17B | $0.56B | 10.78% |
| 2007-01-31 | $5.09B | $0.52B | 10.30% |
| 2006-10-31 | $4.97B | $0.46B | 9.33% |
| 2006-07-31 | $4.60B | $0.42B | 9.05% |
| 2006-04-30 | $4.60B | $0.27B | 5.85% |
| 2006-01-31 | $4.64B | $0.21B | 4.59% |
| 2005-10-31 | $4.69B | $0.22B | 4.61% |
| 2005-07-31 | $5.07B | $0.19B | 3.81% |
| 2005-04-30 | $5.71B | $0.27B | 4.64% |
| 2005-01-31 | $6.26B | $0.33B | 5.33% |
| 2004-10-31 | $6.70B | $0.38B | 5.60% |
| 2004-07-31 | $7.03B | $0.35B | 5.02% |
| 2004-04-30 | $6.65B | $0.06B | 0.84% |
| 2004-01-31 | $6.29B | $-0.39B | -6.20% |
| 2003-10-31 | $6.06B | $-0.73B | -11.97% |
| 2003-07-31 | $6.12B | $-1.17B | -19.09% |
| 2003-04-30 | $6.01B | $-1.41B | -23.43% |
| 2003-01-31 | $6.00B | $-1.42B | -23.70% |
| 2002-10-31 | $6.01B | $-1.61B | -26.74% |
| 2002-07-31 | $5.88B | $-1.91B | -32.52% |
| 2002-04-30 | $6.31B | $-1.81B | -28.76% |
| 2002-01-31 | $7.26B | $-1.51B | -20.86% |
| 2001-10-31 | $8.40B | $-0.78B | -9.27% |
| 2001-07-31 | $10.16B | $0.37B | 3.66% |
| 2001-04-30 | $10.69B | $0.89B | 8.34% |
| 2001-01-31 | $10.43B | $1.13B | 10.79% |
| 2000-10-31 | $10.11B | $1.00B | 9.91% |
| 2000-07-31 | $9.19B | $2.99B | 32.57% |
| 2000-04-30 | $8.92B | $3.00B | 33.60% |
| 2000-01-31 | $8.79B | $3.05B | 34.74% |
| 1999-10-31 | $8.33B | $4.67B | 56.04% |
| 1999-07-31 | $7.87B | $4.21B | 53.47% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $36.486B | $6.948B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.241B | 21.80 |
| EssilorLuxottica (ESLOY) | France | $138.190B | 0.00 |
| Stryker (SYK) | United States | $138.078B | 26.49 |
| Medtronic (MDT) | Ireland | $130.022B | 18.01 |
| Boston Scientific (BSX) | United States | $110.071B | 24.34 |
| Medline (MDLN) | United States | $59.498B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.159B | 0.00 |
| ResMed (RMD) | United States | $38.392B | 25.64 |
| GE HealthCare Technologies (GEHC) | United States | $36.105B | 17.30 |
| Koninklijke Philips (PHG) | Netherlands | $31.690B | 18.81 |
| Terumo (TRUMY) | Japan | $20.046B | 22.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.114B | 11.15 |
| Insulet (PODD) | United States | $17.756B | 55.11 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.032B | 0.00 |
| Baxter (BAX) | United States | $11.278B | 9.10 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.091B | 29.09 |
| Demant (WILYY) | Denmark | $6.264B | 0.00 |
| Envista Holdings (NVST) | United States | $4.961B | 25.14 |
| Lantheus Holdings (LNTH) | United States | $4.454B | 13.57 |
| BillionToOne (BLLN) | United States | $4.208B | 0.00 |
| ICU Medical (ICUI) | United States | $3.782B | 24.02 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.128B | 14.76 |
| Haemonetics (HAE) | United States | $2.763B | 12.09 |
| Neogen (NEOG) | United States | $2.334B | 51.10 |
| Phibro Animal Health (PAHC) | United States | $2.097B | 18.48 |
| LeMaitre Vascular (LMAT) | United States | $1.996B | 40.17 |
| QuidelOrtho (QDEL) | United States | $1.984B | 12.76 |
| Perrigo (PRGO) | Ireland | $1.980B | 4.96 |
| AtriCure (ATRC) | United States | $1.882B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.615B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.593B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.441B | 20.86 |
| Green Thumb Industries (GTBIF) | United States | $1.423B | 62.36 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.325B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.126B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.091B | 323.57 |
| InMode (INMD) | Israel | $0.924B | 10.15 |
| Tilray Brands (TLRY) | Canada | $0.912B | 0.00 |
| Valneva SE (VALN) | France | $0.846B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.798B | 0.00 |
| Omeros (OMER) | United States | $0.792B | 0.00 |
| CeriBell (CBLL) | United States | $0.771B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.593B | 14.15 |
| Brainsway (BWAY) | Israel | $0.457B | 77.83 |
| Verano Holdings (VRNO) | United States | $0.447B | 0.00 |
| Cerus (CERS) | United States | $0.428B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
| SNDL (SNDL) | Canada | $0.384B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.368B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 25.12 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Evolus (EOLS) | United States | $0.288B | 0.00 |
| Quanterix (QTRX) | United States | $0.286B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.227B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.221B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| High Tide (HITI) | Canada | $0.209B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.207B | 18.54 |
| Aurora Cannabis (ACB) | Canada | $0.202B | 59.33 |
| OraSure Technologies (OSUR) | United States | $0.202B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.200B | 0.00 |
| Organigram Global (OGI) | Canada | $0.188B | 0.00 |
| Accendra Health (ACH) | United States | $0.184B | 1.85 |
| Sanara MedTech (SMTI) | United States | $0.174B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.166B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.152B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.135B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.135B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.86 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
| Biote (BTMD) | United States | $0.101B | 4.42 |
| Exagen (XGN) | United States | $0.079B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.50 |
| Sharps Technology (STSS) | United States | $0.049B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 29.92 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.033B | 0.00 |
| United-Guardian (UG) | United States | $0.031B | 15.56 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |